You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR KETOPROFEN


✉ Email this page to a colleague

« Back to Dashboard


505(b)(2) Clinical Trials for KETOPROFEN

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
New Formulation NCT04678076 ↗ Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution Completed Cross Research S.A. Phase 1 2018-07-23 This is a single dose, open-label, randomised, two period, two-way cross-over, two stage bioequivalenve study with the aim to investigate the bioequivalence between a new formulation of ketoprofen 25 mg versus OKI 80 mg granules for oral solution (half sachet), after single dose administration in two consecutive periods to healthy voluteers under fed conditions.
New Formulation NCT04678076 ↗ Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution Completed Aziende Chimiche Riunite Angelini Francesco S.p.A Phase 1 2018-07-23 This is a single dose, open-label, randomised, two period, two-way cross-over, two stage bioequivalenve study with the aim to investigate the bioequivalence between a new formulation of ketoprofen 25 mg versus OKI 80 mg granules for oral solution (half sachet), after single dose administration in two consecutive periods to healthy voluteers under fed conditions.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for KETOPROFEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00108810 ↗ Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee Completed ZARS Pharma Inc. Phase 2 2005-04-01 The purpose of the study is to evaluate the safety and effectiveness of the investigational ketoprofen patch with a controlled heating patch, compared to placebo (inactive substance) for the treatment of pain caused by osteoarthritis.
NCT00188071 ↗ Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen Completed University Hospital, Angers N/A 2002-09-01 - To compare postoperative analgesia by paracetamol 1gr or ketoprofen 100 mg or the combination of these two analgesics - each treatment beeing allocated by randomization
NCT00265304 ↗ A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee Completed IDEA AG Phase 2 2005-07-01 The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving drug taken by mouth) for the treatment of osteoarthritis of both knees.
NCT00317733 ↗ Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the Knee Completed IDEA AG Phase 2 1969-12-31 The purpose of this study is to determine the safety and effectiveness of 110 mg ketoprofen in Transfersome applied to the skin twice daily as compared to placebo and oral celecoxib 200 mg per day for the relief of signs and symptoms of osteoarthritis of the knee for a period of six weeks.
NCT00351104 ↗ Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain Completed APR Applied Pharma Research s.a. Phase 3 2006-06-01 The purpose of this study is to evaluate the effect of a ketoprofen topical patch on the pain associated with ankle sprain or strain.
NCT00351104 ↗ Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain Completed Endo Pharmaceuticals Phase 3 2006-06-01 The purpose of this study is to evaluate the effect of a ketoprofen topical patch on the pain associated with ankle sprain or strain.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for KETOPROFEN

Condition Name

Condition Name for KETOPROFEN
Intervention Trials
Pain, Postoperative 8
Postoperative Pain 7
Pain 7
Migraine 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for KETOPROFEN
Intervention Trials
Pain, Postoperative 18
Osteoarthritis 14
Osteoarthritis, Knee 12
Postoperative Nausea and Vomiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for KETOPROFEN

Trials by Country

Trials by Country for KETOPROFEN
Location Trials
United States 137
Brazil 20
France 17
Italy 15
Egypt 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for KETOPROFEN
Location Trials
Texas 10
California 8
North Carolina 7
Florida 7
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for KETOPROFEN

Clinical Trial Phase

Clinical Trial Phase for KETOPROFEN
Clinical Trial Phase Trials
Phase 4 34
Phase 3 36
Phase 2/Phase 3 3
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for KETOPROFEN
Clinical Trial Phase Trials
Completed 67
Unknown status 11
Terminated 5
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for KETOPROFEN

Sponsor Name

Sponsor Name for KETOPROFEN
Sponsor Trials
Sanofi 5
IDEA AG 5
Endo Pharmaceuticals 4
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for KETOPROFEN
Sponsor Trials
Other 90
Industry 40
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.